You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RLT

Showing 26 - 50 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration Resistant Prostate Cancer Trial in Houston (Ac225-PSMA I&T)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ac225-PSMA I&T
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jan 27, 2022

Liver Metastases Trial in Aurora, Providence (anti-CEA CAR-T cells)

Completed
  • Liver Metastases
  • anti-CEA CAR-T cells
  • Aurora, Colorado
  • +1 more
Oct 20, 2021

Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

Terminated
Has Results
  • Unresectable or Metastatic Melanoma
  • Ipilimumab
  • +3 more
  • New York, New York
  • +4 more
Oct 3, 2022

Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer Trial in United States (Nab-Paclitaxel, Gemcitabine,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Cancer
  • Palo Alto, California
  • +10 more
May 26, 2020

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Acute Myeloid Leukemia Trial in Augusta, Baltimore (Idarubicin, Cytarabine, Indoximod Freebase)

Completed
  • Acute Myeloid Leukemia
  • Augusta, Georgia
  • +1 more
Jun 3, 2020

Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

Enrolling by invitation
  • Dopamine D2/3 Receptor Availability
  • +2 more
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01, 1.85 GBq (50 mCi) of

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 6, 2022

Acute Myeloid Leukemia Trial in Baltimore (Calaspargase pegol-mknl)

Recruiting
  • Acute Myeloid Leukemia
  • Calaspargase pegol-mknl
  • Baltimore, Maryland
    Greenebaum Cancer Center, University of Maryland Medical Systems
Dec 14, 2021

Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • (no location specified)
Jul 28, 2023

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in San Francisco

Active, not recruiting
  • Castration Levels of Testosterone
  • +6 more
  • Lutetium Lu 177-PSMA-617
  • Pembrolizumab
  • San Francisco, California
    University of California, San Francisco
Apr 11, 2022

Metabolic Bone Disease Trial in Elche, Almería, Murcia (Reflex Locomotion Therapy, Passive Joint Mobilizations, Massage)

Completed
  • Metabolic Bone Disease
  • Reflex Locomotion Therapy
  • +2 more
  • Elche, Alicante, Spain
  • +2 more
Nov 27, 2020

Depression Trial in Atlanta (Infliximab, Placebo)

Active, not recruiting
  • Depression
  • Atlanta, Georgia
    Emory University
Jan 23, 2023

Activity Trackers and COVID-19 Infections

Completed
  • Covid19
  • SARS-CoV Infection
    • San Mateo, California
      Evidation Health
    Dec 20, 2021

    Prostate Tumor Trial in Nijmegen (Lu-177 PSMA-617)

    Completed
    • Prostate Neoplasm
    • Lu-177 PSMA-617
    • Nijmegen, Gelderland, Netherlands
      Radiology and Nuclear Medicine
    Nov 13, 2019

    Malignant Glioma Trial in Germany (IDH1R132H peptide vaccine, Avelumab)

    Recruiting
    • Malignant Glioma
    • Berlin, Germany
    • +9 more
    Feb 1, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (225Ac-PSMA)

    Unknown status
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Jan 8, 2020

    Abdominal Cancer Trial in Ottawa (Cialis, Influenza vaccine)

    Recruiting
    • Abdominal Cancer
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Dec 27, 2020

    Knee Osteoarthritis Trial (Tele-prehabilitation, Standard prehabilitation)

    Not yet recruiting
    • Knee Osteoarthritis
    • Tele-prehabilitation
    • Standard prehabilitation
    • (no location specified)
    Dec 20, 2022

    Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)

    Completed
    • Metastatic Melanoma
    • +2 more
    • Augusta, Georgia
    • +5 more
    Jun 3, 2020

    Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

    Completed
    • Glioblastoma Multiforme
    • +3 more
    • Castro Valley, California
    • +16 more
    May 26, 2020

    Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Lille, France
    • +6 more
    Jan 23, 2023

    Glioblastoma Trial in France, Portugal, Spain ([177Lu]Lu-DOTA-TATE, [68Ga]Ga-DOTA-TATE, Temozolomide)

    Recruiting
    • Glioblastoma
    • Bron, France
    • +8 more
    Jan 23, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Nanjing (177 Lu-PSMA-I&T)

    Unknown status
    • Metastatic Castration-resistant Prostate Cancer
    • 177 Lu-PSMA-I&T
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Dec 4, 2019

    Allergic Rhinitis Due to Grass Pollen, Allergic Asthma Trial in Vienna (Nasal Secretion Sampling)

    Completed
    • Allergic Rhinitis Due to Grass Pollen
    • Allergic Asthma
    • Nasal Secretion Sampling
    • Vienna, Austria
      8H1.02, ENT Lab, Department of Otorhinolaryngology, Vienna Gener
    Aug 12, 2021